Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Sell
C
Sonoma Pharmaceuticals, Inc. Common Stock (SNOA)
Pharmaceutical Preparations
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
5445 CONESTOGA COURT, SUITE 150
BOULDER, CO
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/25/2007
Market Cap
4,371,012
Shares Outstanding
13,680,000
Weighted SO
13,679,333
Total Employees
N/A
Upcoming Earnings
N/A
Beta
1.3750
Last Div
0.0000
Range
0.12-1.02
Chg
-0.0049
Avg Vol
5179496
Mkt Cap
4371012
Exch
NASDAQ
Country
US
Phone
800 759 9305
DCF Diff
1.9465
DCF
3.9665
Div Yield
0.0000
P/S
0.3442
EV Multiple
-0.4933
P/FV
0.7873
Div Yield %
0.0000
P/E
-0.8589
PEG
-0.0132
Payout
0.0000
Current Ratio
3.1165
Quick Ratio
2.4079
Cash Ratio
0.6902
DSO
93.3266
DIO
123.5571
Op Cycle
216.8837
DPO
34.9102
CCC
181.9735
Gross Margin
0.3817
Op Margin
-0.3649
Pretax Margin
-0.3604
Net Margin
-0.3591
Eff Tax Rate
0.0037
ROA
-0.3335
ROE
-0.7769
ROCE
-0.4670
NI/EBT
0.9963
EBT/EBIT
0.9877
EBIT/Rev
-0.3649
Debt Ratio
0.0307
D/E
0.0844
LT Debt/Cap
0.0121
Total Debt/Cap
0.0778
Int Coverage
0.0000
CF/Debt
-7.3690
Equity Multi
2.7483
Rec Turnover
3.9110
Pay Turnover
10.4554
Inv Turnover
2.9541
FA Turnover
24.5154
Asset Turnover
0.9288
OCF/Share
-0.1817
FCF/Share
-0.1820
Cash/Share
0.1520
OCF/Sales
-0.2437
FCF/OCF
1.0016
CF Coverage
-7.3690
ST Coverage
-8.6212
CapEx Coverage
-619.0000
Div&CapEx Cov
-619.0000
P/BV
0.7873
P/B
0.7873
P/S
0.3442
P/E
-0.8589
P/FCF
-1.4100
P/OCF
-1.2655
P/CF
-1.2655
PEG
-0.0132
P/S
0.3442
EV Multiple
-0.4933
P/FV
0.7873
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
60.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
175.76K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 3.66M | ▲ 4.38M | ▲ 4.58M | ▼ 2.16M | ▲ 2.30M | ▲ 3.01M | ▲ 3.44M |
Cost Of Revenue | 2.32M | ▲ 2.51M | ▲ 3.07M | ▼ 2.35M | ▼ 2.20M | ▼ 2.15M | ▲ 2.35M |
Gross Profit | 1.33M | ▲ 1.88M | ▼ 1.51M | ▼ -194.00K | ▲ 96.00K | ▲ 864.00K | ▲ 1.09M |
Gross Profit Ratio | 0.36 | ▲ 0.43 | ▼ 0.33 | ▼ -0.09 | ▲ 0.04 | ▲ 0.29 | ▲ 0.32 |
Research And Development Expenses | 476.00K | ▼ 327.00K | ▲ 483.00K | ▼ 130.00K | ▼ 4.00K | ▲ 201.00K | ▲ 409.00K |
General And Administrative Expenses | 5.61M | ▼ 4.25M | ▼ 3.79M | ▼ 0.00 | 0.00 | ▲ 1.65M | ▼ 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 156.00K | ▼ 0.00 |
Selling General And Administrative Expenses | 5.61M | ▼ 4.25M | ▼ 3.79M | ▼ 2.49M | ▲ 3.15M | ▼ 1.81M | ▲ 2.09M |
Other Expenses | -178.00K | ▲ -104.00K | ▲ 474.00K | ▼ 93.00K | ▼ -936.00K | ▲ -304.00K | ▲ 50.00K |
Operating Expenses | 6.08M | ▼ 4.58M | ▼ 4.27M | ▼ 2.62M | ▲ 3.16M | ▼ 2.01M | ▲ 2.50M |
Cost And Expenses | 8.40M | ▼ 7.09M | ▲ 7.34M | ▼ 4.97M | ▲ 5.36M | ▼ 4.16M | ▲ 4.85M |
Interest Income | 173.00K | ▼ 51.00K | ▼ -67.00K | ▲ 2.00K | ▼ 0.00 | ▲ 12.00K | ▼ 0.00 |
Interest Expense | 9.00K | ▼ 7.00K | ▼ 3.00K | ▼ 0.00 | ▼ -9.00K | ▲ 292.00K | ▼ 0.00 |
Depreciation And Amortization | 124.00K | ▼ 106.00K | ▼ 100.00K | ▼ 40.00K | ▼ -674.00K | ▲ 34.00K | ▲ 41.00K |
Ebitda | -4.75M | ▲ -2.65M | ▲ -2.25M | ▼ -2.68M | ▼ -3.73M | ▲ -1.11M | ▼ -1.37M |
Ebitda Ratio | -1.30 | ▲ -0.60 | ▲ -0.49 | ▼ -1.24 | ▼ -1.62 | ▲ -0.37 | ▼ -0.40 |
Operating Income | -4.75M | ▲ -2.70M | ▼ -2.76M | ▼ -2.81M | ▼ -3.06M | ▲ -1.15M | ▼ -1.41M |
Operating Income Ratio | -1.30 | ▲ -0.62 | ▲ -0.60 | ▼ -1.30 | ▼ -1.33 | ▲ -0.38 | ▼ -0.41 |
Total Other Income Expenses Net | -178.00K | ▲ -104.00K | ▲ 1.57M | ▼ 93.00K | ▼ -222.00K | ▼ -292.00K | ▲ 50.00K |
Income Before Tax | -4.76M | ▲ -2.76M | ▲ -1.25M | ▼ -2.72M | ▼ -3.28M | ▲ -1.44M | ▲ -1.36M |
Income Before Tax Ratio | -1.30 | ▲ -0.63 | ▲ -0.27 | ▼ -1.26 | ▼ -1.43 | ▲ -0.48 | ▲ -0.40 |
Income Tax Expense | -293.00K | ▲ 361.00K | ▲ 598.00K | ▲ 1.03M | ▼ -338.00K | ▲ -131.00K | ▼ -292.00K |
Net Income | -4.76M | ▲ -3.22M | ▲ -1.37M | ▼ -3.66M | ▲ -2.94M | ▲ -1.31M | ▲ -1.07M |
Net Income Ratio | -1.30 | ▲ -0.74 | ▲ -0.30 | ▼ -1.70 | ▲ -1.28 | ▲ -0.43 | ▲ -0.31 |
Eps | -8.35 | ▲ -2.45 | ▲ -0.75 | ▼ -1.78 | ▲ -1.11 | ▲ -0.28 | ▲ -0.07 |
Eps Diluted | -8.35 | ▲ -2.45 | ▲ -0.75 | ▼ -1.78 | ▲ -1.11 | ▲ -0.28 | ▲ -0.07 |
Weighted Average Shs Out | 570.44K | ▲ 1.31M | ▲ 1.77M | ▲ 2.05M | ▲ 2.65M | ▲ 4.68M | ▲ 15.61M |
Weighted Average Shs Out Dil | 570.44K | ▲ 1.32M | ▲ 1.84M | ▲ 2.05M | ▲ 2.65M | ▲ 4.68M | ▲ 15.61M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 10.07M | ▼ 3.69M | ▲ 3.69M | ▲ 4.22M | ▲ 7.40M | ▼ 3.82M | ▼ 3.13M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 10.07M | ▼ 3.69M | ▲ 3.69M | ▲ 4.22M | ▲ 7.40M | ▼ 3.82M | ▼ 3.13M |
Net Receivables | 1.54M | ▲ 4.44M | ▲ 5.37M | ▼ 4.66M | ▲ 4.78M | ▲ 6.42M | ▼ 2.90M |
Inventory | 2.87M | ▲ 3.41M | ▼ 2.19M | ▲ 2.53M | ▲ 2.66M | ▲ 2.86M | ▼ 2.72M |
Other Current Assets | 1.55M | ▼ 299.00K | ▲ 428.00K | ▲ 663.00K | ▲ 1.59M | ▼ 703.00K | ▲ 3.54M |
Total Current Assets | 16.25M | ▼ 12.50M | ▼ 12.38M | ▲ 12.98M | ▲ 16.43M | ▼ 13.80M | ▼ 12.29M |
Property Plant Equipment Net | 1.14M | ▼ 727.00K | ▲ 1.33M | ▼ 1.13M | ▼ 879.00K | ▲ 906.00K | ▼ 651.00K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 829.00K | ▲ 949.00K | ▲ 1.30M |
Other Non Current Assets | 1.82M | ▼ 1.23M | ▼ 850.00K | ▲ 875.00K | ▼ 707.00K | ▼ 578.00K | ▲ 658.00K |
Total Non Current Assets | 2.95M | ▼ 1.95M | ▲ 2.18M | ▼ 2.00M | ▲ 2.42M | ▲ 2.43M | ▲ 2.61M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 19.21M | ▼ 14.45M | ▲ 14.56M | ▲ 14.99M | ▲ 18.85M | ▼ 16.23M | ▼ 14.89M |
Account Payables | 1.27M | ▼ 1.26M | ▲ 2.09M | ▼ 1.77M | ▼ 1.64M | ▼ 841.00K | ▼ 607.00K |
Short Term Debt | 377.00K | ▲ 463.00K | ▲ 732.00K | ▲ 836.00K | ▲ 1.06M | ▼ 687.00K | ▼ 521.00K |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 4.24M | ▼ 0.00 |
Deferred Revenue | 206.00K | ▼ 102.00K | ▲ 273.00K | ▲ 319.00K | ▲ 1.28M | ▼ 160.00K | ▲ 478.00K |
Other Current Liabilities | 1.41M | ▲ 1.77M | ▲ 1.77M | ▼ 1.15M | ▲ 1.84M | ▲ 2.03M | ▲ 2.11M |
Total Current Liabilities | 3.26M | ▲ 3.59M | ▲ 4.87M | ▼ 4.08M | ▲ 5.82M | ▼ 3.72M | ▲ 3.72M |
Long Term Debt | 176.00K | ▼ 12.00K | ▲ 746.00K | ▲ 1.84M | ▼ 309.00K | ▼ 162.00K | ▼ 87.00K |
Deferred Revenue Non Current | 443.00K | ▼ 356.00K | ▼ 245.00K | ▼ 229.00K | ▼ 182.00K | ▼ 140.00K | ▼ 87.00K |
Deferred Tax Liabilities Non Current | -144.00K | ▲ 0.00 | ▼ -746.00K | ▲ 0.00 | 0.00 | ▲ 178.00K | ▼ 153.00K |
Other Non Current Liabilities | 144.00K | ▼ 0.00 | ▲ 746.00K | ▲ 3.48M | ▲ 3.84M | ▲ 4.06M | ▲ 4.71M |
Total Non Current Liabilities | 619.00K | ▼ 368.00K | ▲ 991.00K | ▲ 5.55M | ▼ 4.33M | ▲ 4.54M | ▲ 5.04M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 291.00K | ▼ 141.00K | ▲ 997.00K | ▼ 769.00K | ▼ 559.00K | ▼ 418.00K | ▼ 87.00K |
Total Liabilities | 3.88M | ▲ 3.96M | ▲ 5.86M | ▲ 9.62M | ▲ 10.15M | ▼ 8.25M | ▲ 8.76M |
Preferred Stock | 0.00 | ▲ 349.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 1.00K | ▲ 2.00K | 2.00K | 2.00K | 2.00K | ▲ 5.00K | ▼ 2.00K |
Retained Earnings | -157.44M | ▼ -169.24M | ▼ -172.25M | ▼ -179.28M | ▼ -184.36M | ▼ -189.51M | ▼ -194.35M |
Accumulated Other Comprehensive Income Loss | -3.98M | ▼ -4.35M | ▼ -5.61M | ▲ -4.58M | ▲ -4.31M | ▲ -3.42M | ▲ -2.72M |
Other Total Stockholders Equity | 176.77M | ▲ 183.73M | ▲ 186.95M | ▲ 189.22M | ▲ 197.37M | ▲ 200.90M | ▲ 203.21M |
Total Stockholders Equity | 15.33M | ▼ 10.49M | ▼ 8.71M | ▼ 5.36M | ▲ 8.70M | ▼ 7.98M | ▼ 6.14M |
Total Equity | 15.33M | ▼ 10.49M | ▼ 8.71M | ▼ 5.36M | ▲ 8.70M | ▼ 7.98M | ▼ 6.14M |
Total Liabilities And Stockholders Equity | 19.21M | ▼ 14.45M | ▲ 14.56M | ▲ 14.99M | ▲ 18.85M | ▼ 16.23M | ▼ 14.89M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 19.21M | ▼ 14.45M | ▲ 14.56M | ▲ 14.99M | ▲ 18.85M | ▼ 16.23M | ▼ 14.89M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 553.00K | ▼ 475.00K | ▲ 1.48M | ▲ 2.68M | ▼ 1.37M | ▼ 849.00K | ▼ 608.00K |
Net Debt | -9.51M | ▲ -3.21M | ▲ -2.21M | ▲ -1.55M | ▼ -6.03M | ▲ -2.97M | ▲ -2.52M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -4.76M | ▲ -3.22M | ▲ -1.37M | ▼ -3.66M | ▲ -2.94M | ▲ -1.31M | ▲ -1.07M |
Depreciation And Amortization | 124.00K | ▼ 106.00K | ▼ 100.00K | ▼ 40.00K | ▲ 49.00K | ▼ 34.00K | ▲ 41.00K |
Deferred Income Tax | 651.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | ▲ 206.00K | ▼ -201.00K |
Stock Based Compensation | 880.00K | ▼ 360.00K | ▼ 302.00K | ▼ 55.00K | ▲ 212.00K | ▼ 100.00K | ▼ 69.00K |
Change In Working Capital | 32.00K | ▲ 810.00K | ▼ -1.85M | ▲ 2.73M | ▲ 3.28M | ▼ -1.34M | ▲ 1.15M |
Accounts Receivables | 511.00K | ▼ 464.00K | ▼ -684.00K | ▲ 2.14M | ▼ 2.03M | ▼ -67.00K | ▲ -9.00K |
Inventory | -62.00K | ▼ -265.00K | ▼ -307.00K | ▲ 338.00K | ▼ 266.00K | ▼ 162.00K | ▲ 277.00K |
Accounts Payables | -142.00K | ▲ 155.00K | ▼ -548.00K | ▼ -628.00K | ▲ 32.00K | ▼ -511.00K | ▲ -266.00K |
Other Working Capital | -275.00K | ▲ 456.00K | ▼ -307.00K | ▲ 875.00K | ▲ 949.00K | ▼ -921.00K | ▲ 1.50M |
Other Non Cash Items | 28.00K | ▼ -800.00K | ▲ -773.00K | ▲ -640.00K | ▼ -1.99M | ▲ -136.00K | ▲ 310.00K |
Net Cash Provided By Operating Activities | -3.05M | ▲ -2.75M | ▼ -3.59M | ▲ -1.48M | ▲ -1.40M | ▼ -2.44M | ▲ 152.00K |
Investments In Property Plant And Equipment | -9.00K | ▼ -14.00K | ▼ -120.00K | ▲ -5.00K | ▼ -62.00K | ▼ -190.00K | ▲ 3.00K |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 1.00K | ▲ 6.00K | ▲ 3.80M | ▼ 1.00K | 1.00K | ▲ 108.00K | ▼ 15.00K |
Net Cash Used For Investing Activities | -8.00K | -8.00K | ▲ 3.68M | ▼ -4.00K | ▼ -61.00K | ▼ -82.00K | ▲ 18.00K |
Debt Repayment | -62.00K | ▼ -81.00K | ▲ 0.00 | 0.00 | ▲ 222.00K | ▼ -674.00K | ▲ -94.00K |
Common Stock Issued | 4.50M | ▼ 1.00K | ▼ 0.00 | 0.00 | 0.00 | ▲ 2.96M | ▼ 338.00K |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | ▲ 269.00K | ▼ 0.00 | ▲ 2.70M | ▼ 378.00K |
Net Cash Used Provided By Financing Activities | 4.44M | ▼ -80.00K | ▲ 0.00 | ▲ 269.00K | ▼ 222.00K | ▲ 3.37M | ▼ 622.00K |
Effect Of Forex Changes On Cash | 59.00K | ▼ 27.00K | ▼ -125.00K | ▲ -110.00K | ▲ 101.00K | ▲ 337.00K | ▼ -70.00K |
Net Change In Cash | 1.44M | ▼ -2.81M | ▲ -36.00K | ▼ -1.32M | ▲ -1.13M | ▲ 1.19M | ▼ 722.00K |
Cash At End Of Period | 10.07M | ▼ 3.69M | ▲ 3.69M | ▲ 4.22M | ▲ 7.40M | ▼ 3.82M | ▼ 3.13M |
Cash At Beginning Of Period | 8.63M | ▼ 6.50M | ▼ 3.73M | ▲ 5.54M | ▲ 8.53M | ▼ 2.63M | ▼ 2.41M |
Operating Cash Flow | -3.05M | ▲ -2.75M | ▼ -3.59M | ▲ -1.48M | ▲ -1.40M | ▼ -2.44M | ▲ 152.00K |
Capital Expenditure | -9.00K | ▼ -14.00K | ▼ -120.00K | ▲ -5.00K | ▼ -62.00K | ▼ -190.00K | ▲ 3.00K |
Free Cash Flow | -3.06M | ▲ -2.76M | ▼ -3.71M | ▲ -1.48M | ▲ -1.46M | ▼ -2.63M | ▲ 155.00K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)